What are the recent financial highlights of SOLARA ACTIVE PHA SCI LTD?

SOLARA ACTIVE PHA SCI LTD recently reported a total revenue of ₹1,310.18 Cr and a net profit margin of -19.29%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of SOLARA ACTIVE PHA SCI LTD?

Key financial metrics include a trailing P/E ratio of , forward P/E of 14.907692, book value of ₹344.381, price-to-book ratio of 1.406872, and a market capitalization of ₹20.63 billion.

What does SOLARA ACTIVE PHA SCI LTD do?

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Solara

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Solara

Latest updates related to Solara

Sr No.	Title	Sentiment
1	Solara Active Pharma Sciences, MIC Electronics, GTL Infrastructure and Wockhardt hit the upper circuit on Friday Upstox	🔄
2	Smallcap index slips 4%, hits 7-month low; Netweb, Newgen, Solara tank 10% Business Standard	🔄
3	Solara Active Pharma Sciences, MIC Electronics, GTL Infrastructure and Wockhardt hit the upper circuit on Friday Upstox	🔄
4	Solara Active Pharma Sciences reports consolidated net profit of Rs 8.09 crore in the December 2024 quarter Business Standard	🔄
5	Ravindra Energy, Solara Active Pharma Sciences and 20 Microns hit the upper circuit Upstox	🔄
6	Smallcap index slips 4%, hits 7-month low; Netweb, Newgen, Solara tank 10% Business Standard	🔄
7	SmallCap pharma stocks in focus; Bliss GVS, Lincoln, Solara zoom up to 20% Business Standard	🔄
8	Solara Active Pharma Sciences Faces Financial Challenges Despite Recent Profit Growth MarketsMojo	🔄
9	SOLARA ACTIVE P Consolidated December 2024 Net Sales at Rs 300.31 crore, up 20.74% Y-o-Y Moneycontrol	🔄
10	SOLARA ACTIVE PHARMA SCIENCES Share Price Today Down 6% Equitymaster	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Loading...

Loading...

Stock News - Solara

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Credit ratings

Concalls

Explore More Stocks